Back to top
more

HEXO Corp. (HEXO)

(Delayed Data from AMEX)

$7.73 USD

7.73
4,769,165

+0.27 (3.62%)

Updated May 3, 2019 04:00 PM ET

After-Market: $7.72 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

HEXO (HEXO) Upgraded to Buy: Here's What You Should Know

by Zacks Equity Research

HEXO (HEXO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Down 22.2% in 4 Weeks, Here's Why HEXO (HEXO) Looks Ripe for a Turnaround

by Zacks Equity Research

HEXO (HEXO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Molson Coors (TAP) Expands CBD Beverage Line With Truss USA

by Zacks Equity Research

Molson Coors (TAP) is likely to strengthen its position in the cannabis beverage market by expanding its Veryvell CBD beverages line through Truss USA.

Madeleine Johnson headshot

Why Cannabis Giant Tilray (TLRY) Skyrocketed Today

by Madeleine Johnson

Shares of Tilray (TLRY) closed sharply higher in Wednesday's trading session, gaining 25.8% after reporting mixed fourth-quarter earnings results.

New Strong Sell Stocks for July 12th

by Zacks Equity Research

ACCD, CMTL, HEXO, NTRB, and GP have been added to the Zacks Rank #5 (Strong Sell) List on July 12, 2021

New Strong Sell Stocks for June 30th

by Zacks Equity Research

CLPR, HEXO, JRSH, MSEX and PDCO have been added to the Zacks Rank #5 (Strong Sell) List on June 30, 2021.

HEXO (HEXO) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

by Zacks Equity Research

HEXO (HEXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HEXO (HEXO) Moves 10% Higher: Will This Strength Last?

by Zacks Equity Research

HEXO (HEXO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

HEXO (HEXO) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

HEXO (HEXO) delivered earnings and revenue surprises of -333.33% and 0.18%, respectively, for the quarter ended January 2021. Do the numbers hold clues to what lies ahead for the stock?

Why HEXO Corp (HEXO) Might Surprise This Earnings Season

by Zacks Equity Research

HEXO Corp (HEXO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

HEXO (HEXO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

by Zacks Equity Research

HEXO (HEXO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HEXO (HEXO) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, HEXO (HEXO) closed at $6.49, marking a +1.09% move from the previous day.

HEXO (HEXO) Stock Moves -0.14%: What You Should Know

by Zacks Equity Research

HEXO (HEXO) closed at $7.30 in the latest trading session, marking a -0.14% move from the prior day.

Cooper Companies (COO) to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

Cooper Companies' (COO) fiscal first-quarter results are likely to reflect strength at MiSight 1-day contact lens.

What's in Store for Patterson Companies' (PDCO) Q3 Earnings?

by Zacks Equity Research

Patterson Companies' (PDCO) fiscal third-quarter results are likely to reflect improvement at Dental segment.

Veeva Systems (VEEV) to Post Q4 Earnings: What's in Store?

by Zacks Equity Research

Veeva Systems' (VEEV) fiscal fourth-quarter results are likely to reflect solid show by its segments and robust product portfolio.

DENTSPLY SIRONA (XRAY) to Post Q4 Earnings: What's in Store?

by Zacks Equity Research

DENTSPLY SIRONA's (XRAY) fourth-quarter results are likely to reflect weak segmental performance.

HEXO Soars: Stock Adds 7.9% in Session

by Zacks Equity Research

HEXO saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

HEXO (HEXO) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, HEXO (HEXO) closed at $7.80, marking a -0.13% move from the previous day.

Sweta Killa headshot

Cannabis ETF Tops in January: 5 Stocks That Led the Way

by Sweta Killa

Inside the top performing stocks in the top ETF of January.

HEXO (HEXO) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

HEXO (HEXO) delivered earnings and revenue surprises of 50.00% and 2.88%, respectively, for the quarter ended October 2020. Do the numbers hold clues to what lies ahead for the stock?

HEXO (HEXO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

HEXO (HEXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HEXO (HEXO) Flat As Market Sinks: What You Should Know

by Zacks Equity Research

HEXO (HEXO) closed at $1.17 in the latest trading session, marking no change from the prior day.

HEXO Catches Eye: Stock Jumps 9.4%

by Zacks Equity Research

HEXO saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

HEXO (HEXO) Gains As Market Dips: What You Should Know

by Zacks Equity Research

HEXO (HEXO) closed the most recent trading day at $0.76, moving +1.86% from the previous trading session.